Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
February 12, 2016 at 11:09 AM EST
Clovis Oncology Inc (NASDAQ: CLVS) announced on Friday that the U.S. Food and Drug Administration has scheduled a date of April 12, 2016 ...
